Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

drug ocean llc - midodrine hydrochloride (unii: 59jv96ytxv) (midodrine - unii:6ye7pbm15h) - midodrine hydrochloride tablets are indicated for the treatment of symptomatic orthostatic hypotension (oh). because midodrine hydrochloride tablets can cause marked elevation of supine blood pressure (bp > 200 mmhg systolic), it should be used in patients whose lives are considerably impaired despite standard clinical care, including non-pharmacologic treatment (such as support stockings), fluid expansion, and lifestyle alterations. the indication is based on midodrine hydrochloride tablets's effect on increases in 1-minute standing systolic blood pressure, a surrogate marker considered likely to correspond to a clinical benefit. at present, however, clinical benefits of midodrine hydrochloride tablets, principally improved ability to perform life activities, have not been established. further clinical trials are underway to verify and describe the clinical benefits of midodrine hydrochloride tablets. after initiation of treatment, midodrine hydrochloride tablets should be continued only for patients who report significant symptomatic improvement. midodrine hydrochloride tablets are contraindicated in patients with severe organic heart disease, acute renal disease, urinary retention, pheochromocytoma or thyrotoxicosis. midodrine hydrochloride tablets should not be used in patients with persistent and excessive supine hypertension.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

bryant ranch prepack - midodrine hydrochloride (unii: 59jv96ytxv) (midodrine - unii:6ye7pbm15h) - midodrine hydrochloride tablets are indicated for the treatment of symptomatic orthostatic hypotension (oh). because midodrine hydrochloride tablets can cause marked elevation of supine blood pressure (bp > 200 mmhg systolic), it should be used in patients whose lives are considerably impaired despite standard clinical care, including non-pharmacologic treatment (such as support stockings), fluid expansion, and lifestyle alterations. the indication is based on midodrine hydrochloride tablets's effect on increases in 1-minute standing systolic blood pressure, a surrogate marker considered likely to correspond to a clinical benefit. at present, however, clinical benefits of midodrine hydrochloride tablets, principally improved ability to perform life activities, have not been established. further clinical trials are underway to verify and describe the clinical benefits of midodrine hydrochloride tablets. after initiation of treatment, midodrine hydrochloride tablets should be continued only for patients who rep

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

rising pharmaceuticals, inc. - midodrine hydrochloride (unii: 59jv96ytxv) (midodrine - unii:6ye7pbm15h) - midodrine hydrochloride tablets are indicated for the treatment of symptomatic orthostatic hypotension (oh). because midodrine hydrochloride tablets can cause marked elevation of supine blood pressure (bp > 200 mmhg systolic), it should be used in patients whose lives are considerably impaired despite standard clinical care, including non-pharmacologic treatment (such as support stockings), fluid expansion, and lifestyle alterations. the indication is based on midodrine hydrochloride tablets's effect on increases in 1-minute standing systolic blood pressure, a surrogate marker considered likely to correspond to a clinical benefit. at present, however, clinical benefits of midodrine hydrochloride tablets, principally improved ability to perform life activities, have not been established. further clinical trials are underway to verify and describe the clinical benefits of midodrine hydrochloride tablets. after initiation of treatment, midodrine hydrochloride tablets should be continued only for patients who rep

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

medsurge pharma limited - midodrine hydrochloride 2.5mg - tablet - 2.5 mg - active: midodrine hydrochloride 2.5mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose purified talc - midodrine hydrochloride is indicated to attenuate symptoms of chronic orthostatic hypotension due to autonomic failure in patients with bradbury-eggleston or shy-drager syndromes and other medical disorders such as diabetes mellitus or parkinson's disease. because midodrine can cause marked elevation of supine blood pressure, it should only be used in patients whose lives are considerably impaired despite standard clinical care including nonpharmacologic treatment, plasma volume expansion and lifestyle alterations. the initiation of midodrine hydrochloride therapy should be undertaken under close medical supervision in a controlled clinical setting.

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

medsurge pharma limited - midodrine hydrochloride 2.5mg - tablet - 2.5 mg - active: midodrine hydrochloride 2.5mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose purified talc - midodrine hydrochloride is indicated to attenuate symptoms of chronic orthostatic hypotension due to autonomic failure in patients with bradbury-eggleston or shy-drager syndromes and other medical disorders such as diabetes mellitus or parkinson's disease. because midodrine can cause marked elevation of supine blood pressure, it should only be used in patients whose lives are considerably impaired despite standard clinical care including nonpharmacologic treatment, plasma volume expansion and lifestyle alterations. the initiation of midodrine hydrochloride therapy should be undertaken under close medical supervision in a controlled clinical setting.

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

medsurge pharma limited - midodrine hydrochloride 5mg - tablet - 5 mg - active: midodrine hydrochloride 5mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose purified talc sunset yellow aluminium lake - midodrine hydrochloride is indicated to attenuate symptoms of chronic orthostatic hypotension due to autonomic failure in patients with bradbury-eggleston or shy-drager syndromes and other medical disorders such as diabetes mellitus or parkinson's disease. because midodrine can cause marked elevation of supine blood pressure, it should only be used in patients whose lives are considerably impaired despite standard clinical care including nonpharmacologic treatment, plasma volume expansion and lifestyle alterations. the initiation of midodrine hydrochloride therapy should be undertaken under close medical supervision in a controlled clinical setting.

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

medsurge pharma limited - midodrine hydrochloride 5mg - tablet - 5 mg - active: midodrine hydrochloride 5mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose purified talc sunset yellow aluminium lake - midodrine hydrochloride is indicated to attenuate symptoms of chronic orthostatic hypotension due to autonomic failure in patients with bradbury-eggleston or shy-drager syndromes and other medical disorders such as diabetes mellitus or parkinson's disease. because midodrine can cause marked elevation of supine blood pressure, it should only be used in patients whose lives are considerably impaired despite standard clinical care including nonpharmacologic treatment, plasma volume expansion and lifestyle alterations. the initiation of midodrine hydrochloride therapy should be undertaken under close medical supervision in a controlled clinical setting.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - midodrine hydrochloride, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate - midodrine ans is indicated in adults for the treatment of severe symptomatic orthostatic hypotension due to autonomic dysfunction when exacerbating factors have been addressed and other forms of treatment remain inadequate

Australia - engleză - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - midodrine hydrochloride, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate - midodrine scp is indicated in adults for the treatment of severe symptomatic orthostatic hypotension due to autonomic dysfunction when exacerbating factors have been addressed and other forms of treatment remain inadequate.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - midodrine hydrochloride, quantity: 2.5 mg - tablet - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate - midodrine ans is indicated in adults for the treatment of severe symptomatic orthostatic hypotension due to autonomic dysfunction when exacerbating factors have been addressed and other forms of treatment remain inadequate